BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 24515993)

  • 1. Trends in cause of death after percutaneous coronary intervention.
    Spoon DB; Psaltis PJ; Singh M; Holmes DR; Gersh BJ; Rihal CS; Lennon RJ; Moussa ID; Simari RD; Gulati R
    Circulation; 2014 Mar; 129(12):1286-94. PubMed ID: 24515993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer-related deaths among different treatment options in chronic coronary artery disease: results of a 6-year follow-up of the MASS II study.
    Vieira RD; Pereira AC; Lima EG; Garzillo CL; Rezende PC; Favarato D; Hueb AC; Gersh BJ; Ramires JA; Hueb W
    Coron Artery Dis; 2012 Mar; 23(2):79-84. PubMed ID: 22157410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Causes of death in patients undergoing percutaneous coronary intervention with drug-eluting stents in a real-world setting.
    Lee MS; Canan T; Perlowski A; Bhatia R; Jurewitz D; Tobis JM
    J Invasive Cardiol; 2009 Sep; 21(9):441-5. PubMed ID: 19726814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cause of death within 30 days of percutaneous coronary intervention in an era of mandatory outcome reporting.
    Aggarwal B; Ellis SG; Lincoff AM; Kapadia SR; Cacchione J; Raymond RE; Cho L; Bajzer C; Nair R; Franco I; Simpfendorfer C; Tuzcu EM; Whitlow PL; Shishehbor MH
    J Am Coll Cardiol; 2013 Jul; 62(5):409-15. PubMed ID: 23665371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of outcomes of patients ≥ 80 years of age having percutaneous coronary intervention according to presentation (stable vs unstable angina pectoris/non-ST-segment elevation myocardial infarction vs ST-segment elevation myocardial infarction).
    Antonsen L; Jensen LO; Thayssen P; Christiansen EH; Junker A; Tilsted HH; Terkelsen CJ; Kaltoft A; Maeng M; Hansen KN; Ravkilde J; Lassen JF; Madsen M; Sørensen HT; Thuesen L
    Am J Cardiol; 2011 Nov; 108(10):1395-400. PubMed ID: 21890087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex Differences in Long-Term Cause-Specific Mortality After Percutaneous Coronary Intervention: Temporal Trends and Mechanisms.
    Raphael CE; Singh M; Bell M; Crusan D; Lennon RJ; Lerman A; Prasad A; Rihal CS; Gersh BJ; Gulati R
    Circ Cardiovasc Interv; 2018 Mar; 11(3):e006062. PubMed ID: 29540493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of hospital mortality in the elderly undergoing percutaneous coronary intervention for acute coronary syndromes and stable angina.
    Bauer T; Möllmann H; Weidinger F; Zeymer U; Seabra-Gomes R; Eberli F; Serruys P; Vahanian A; Silber S; Wijns W; Hochadel M; Nef HM; Hamm CW; Marco J; Gitt AK
    Int J Cardiol; 2011 Sep; 151(2):164-9. PubMed ID: 20605241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of multivessel coronary disease on one-year clinical outcomes and five-year mortality in patients with ST-elevation myocardial infarction undergoing percutaneous coronary intervention.
    Lekston A; Tajstra M; Gąsior M; Gierlotka M; Pres D; Hudzik B; Trzeciak P; Kalarus Z; Poloński L; Zembala M
    Kardiol Pol; 2011; 69(4):336-43. PubMed ID: 21523666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ten-year outcomes of patients randomized to surgery, angioplasty, or medical treatment for stable multivessel coronary disease: effect of age in the Medicine, Angioplasty, or Surgery Study II trial.
    Rezende PC; Hueb W; Garzillo CL; Lima EG; Hueb AC; Ramires JA; Kalil Filho R
    J Thorac Cardiovasc Surg; 2013 Nov; 146(5):1105-12. PubMed ID: 22944095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term survival after vascular surgery: specific influence of cardiac factors and implications for preoperative evaluation.
    Back MR; Leo F; Cuthbertson D; Johnson BL; Shamesmd ML; Bandyk DF
    J Vasc Surg; 2004 Oct; 40(4):752-60. PubMed ID: 15472605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of coronary artery bypass grafting on specific causes of long-term mortality in the Bypass Angioplasty Revascularization Investigation.
    Holmes DR; Kim LJ; Brooks MM; Kip KE; Schaff HV; Detre KM; Frye RL;
    J Thorac Cardiovasc Surg; 2007 Jul; 134(1):38-46, 46.e1. PubMed ID: 17599484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short- and long-term cause of death in patients treated with primary PCI for STEMI.
    Pedersen F; Butrymovich V; Kelbæk H; Wachtell K; Helqvist S; Kastrup J; Holmvang L; Clemmensen P; Engstrøm T; Grande P; Saunamäki K; Jørgensen E
    J Am Coll Cardiol; 2014 Nov 18-25; 64(20):2101-8. PubMed ID: 25457398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic implications of anemia with or without chronic kidney disease in patients undergoing elective percutaneous coronary intervention.
    Kitai Y; Ozasa N; Morimoto T; Bao B; Furukawa Y; Nakagawa Y; Kadota K; Yanagita M; Shizuta S; Kimura T;
    Int J Cardiol; 2013 Oct; 168(6):5221-8. PubMed ID: 23998544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and multivariable correlates of long-term mortality in patients treated with surgical or percutaneous revascularization in the synergy between percutaneous coronary intervention with taxus and cardiac surgery (SYNTAX) trial.
    Farooq V; Serruys PW; Bourantas C; Vranckx P; Diletti R; Garcia Garcia HM; Holmes DR; Kappetein AP; Mack M; Feldman T; Morice MC; Colombo A; Morel MA; de Vries T; van Es GA; Steyerberg EW; Dawkins KD; Mohr FW; James S; Ståhle E
    Eur Heart J; 2012 Dec; 33(24):3105-13. PubMed ID: 23103663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of optimal medical therapy with or without percutaneous coronary intervention on long-term cardiovascular end points in patients with stable coronary artery disease (from the COURAGE Trial).
    Boden WE; O'Rourke RA; Teo KK; Maron DJ; Hartigan PM; Sedlis SP; Dada M; Labedi M; Spertus JA; Kostuk WJ; Berman DS; Shaw LJ; Chaitman BR; Mancini GB; Weintraub WS;
    Am J Cardiol; 2009 Jul; 104(1):1-4. PubMed ID: 19576311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute coronary syndrome and stable coronary artery disease: are they so different? Long-term outcomes in a contemporary PCI cohort.
    Alcock RF; Yong AS; Ng AC; Chow V; Cheruvu C; Aliprandi-Costa B; Lowe HC; Kritharides L; Brieger DB
    Int J Cardiol; 2013 Aug; 167(4):1343-6. PubMed ID: 22534045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term outcomes after invasive management for older patients with non-ST-segment elevation myocardial infarction.
    Roe MT; Li S; Thomas L; Wang TY; Alexander KP; Ohman EM; Peterson ED
    Circ Cardiovasc Qual Outcomes; 2013 May; 6(3):323-32. PubMed ID: 23652734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aldosterone, mortality, and acute ischaemic events in coronary artery disease patients outside the setting of acute myocardial infarction or heart failure.
    Ivanes F; Susen S; Mouquet F; Pigny P; Cuilleret F; Sautière K; Collet JP; Beygui F; Hennache B; Ennezat PV; Juthier F; Richard F; Dallongeville J; Hillaert MA; Doevendans PA; Jude B; Bertrand M; Montalescot G; Van Belle E
    Eur Heart J; 2012 Jan; 33(2):191-202. PubMed ID: 21719456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Percutaneous revascularization improves outcomes in patients with prior coronary artery bypass surgery.
    Gyenes G; Norris CM; Graham MM;
    Catheter Cardiovasc Interv; 2013 Sep; 82(3):E148-54. PubMed ID: 23208677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison by meta-analysis of percutaneous coronary intervention versus coronary artery bypass grafting in patients with a mean age of ≥70 years.
    Alam M; Virani SS; Shahzad SA; Siddiqui S; Siddiqui KH; Mumtaz SA; Kleiman NS; Coselli JS; Lakkis NM; Jneid H
    Am J Cardiol; 2013 Sep; 112(5):615-22. PubMed ID: 23726179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.